Clemens Achmüller

Title: Clemens Achmüller: Innovator in Biotechnology

Introduction

Clemens Achmüller is a notable inventor based in Kundl, Austria. He has made significant contributions to the field of biotechnology, particularly in recombinant protein expression. With a total of 6 patents, Achmüller has focused on addressing critical challenges in protein expression and genetic stability.

Latest Patents

Achmüller's latest patents include a multi-copy gene protein expression system. This invention addresses two common issues in recombinant protein expression: low protein yield and genetic instability of cell lines. The core principle involves introducing multiple expression cassettes into a cell, each coding for the same mature recombinant protein but with different nucleotide sequences. Another significant patent is related to constitutive yeast LLP promoter-based expression systems. This invention provides a modified eukaryotic cell that lacks the SSN6-like protein, which is crucial for its wildtype function. The invention also includes a polynucleotide sequence with a modified ssn6-like gene and an expression vector that is repressed in the presence of the SSN6-like protein.

Career Highlights

Throughout his career, Achmüller has worked with prominent companies in the biotechnology sector, including Sandoz AG and Boehringer Ingelheim RCV GmbH & Co. KG. His work in these organizations has contributed to advancements in biopharmaceuticals and recombinant technologies.

Collaborations

Achmüller has collaborated with notable colleagues such as Bernhard Auer and Philipp Wechner. These partnerships have fostered innovation and development in the field of biotechnology.

Conclusion

Clemens Achmüller is a distinguished inventor whose work in biotechnology has led to significant advancements in recombinant protein expression. His innovative patents and collaborations continue to impact the field positively.